Reich & Binstock
Free Initial Consultation
Toll Free: 877-643-3099
Local: 713-352-7883
877-643-3099 713-352-7883

Many Risperdal gynecomastia victims have a case

The prescribing information for the antipsychotic Risperdal has a section titled "Other Adverse Reactions Observed During the Premarketing Evaluation of Risperdal." One of the conditions is gynecomastia, which is the development of female-like breasts in males.

The relationship between Risperdal and gynecomastia has shown up in the adverse reactions of young plaintiffs who have filed Risperdal lawsuits. We know now that Risperdal use in children poses an increased risk of gynecomastia. So why didn't the manufacturer of the drug take that into account while it marketed the drug to children despite the FDA's failure to approve the drug for use in children?

Janssen Pharmaceuticals, a Johnson & Johnson company, marketed Risperdal to children from 1999 through 2005. The U.S. Food and Drug Administration, which originally approved Risperdal in 1993, had not cleared the drug for use in adolescents until 2007, according to FDA documents. The government pointed out this off-label marketing of Risperdal in its 2013 plea agreement under which J&J agreed to pay $2.2 billion in civil and criminal penalties stemming from the corporation's marketing scheme.

Risperdal lawsuits are being filed across the country, notably at a trial court in Philadelphia, on behalf of young men who as children used Risperdal and developed gynecomastia. One of the allegations in Risperdal lawsuits is that the manufacturer did not disclose the gynecomastia risk in the drug's youngest male patients - victims to whom the drug was marketed even before the FDA gave its permission. In fact, the FDA warned against that practice. Talk about getting caught red-handed.

Today, many of the injured patients seek recoverable damages. One of the first steps a potential litigant might want to consider is getting a free consultation from one of the experienced attorneys at Reich & Binstock, who without charge can evaluate the circumstances and determine whether there is a viable case for a Risperdal lawsuit.

Reich & Binstock has been fighting for the rights of pharmaceutical injury victims for 30 years. Its attorneys can litigate on behalf of a Risperdal gynecomastia patient in any state. Reich & Binstock's lawyers have considerable skill and expertise in this area of product liability litigation. They have a laudable track record. To get a Reich & Binstock attorney to evaluate your case free-of-charge, simply call toll-free or visit its website and send an electronic message.

No Comments

Leave a comment
Comment Information
Contact Us

Contact Us For Legal Advice

Bold labels are required.

Contact Information
disclaimer.

The use of the Internet or this form for communication with the firm or any individual member of the firm does not establish an attorney-client relationship. Confidential or time-sensitive information should not be sent through this form.

close

Privacy Policy

4265 San Felipe
Suite 1000
Houston, TX 77027

Toll Free: 877-643-3099
Phone: 713-352-7883
Fax: 713-623-8724
Map & Directions